Jack J. Fox
10Patents
8h-index
9Co-inventors
61Inventor score
Filing activity: Apr 16, 1973 → May 6, 1991
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5246924A | Method for treating hepatitis B virus infections using 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-ethyluracil | Human Necessities | 77 | Expired |
| US4211773A | 5-Substituted 1-(2'-Deoxy-2'-substituted-.beta.-D-arabinofuranosyl)pyrimidine nucleosides | Chemistry; Metallurgy | 76 | Expired |
| US4751221A | 2-fluoro-arabinofuranosyl purine nucleosides | Human Necessities | 52 | Expired |
| US4594339A | Anti-herpes virus compositions containing 5-substituted 1-2'(deoxy-2-'-substituted-.beta.-d-arabinofuranosyl)pyrimedene nucleosides | Chemistry; Metallurgy | 37 | Expired |
| US4666892A | Method and composition for hepatitis treatment with pyrimidine nucleoside compounds | Chemistry; Metallurgy | 32 | Expired |
| US4918179A | 2'-fluoro-arabinofuranosyl purine nucleosides | Human Necessities | 23 | Expired |
| US4762823A | Nucleosides of 5-monofluoromethyluracil and 5-difluoromethyluracil | Human Necessities | 18 | Expired |
| US4171429A | Pyrimidine to pyrimidine transformation process | Chemistry; Metallurgy | 12 | Expired |
| US4104461A | 2,2'-Anhydro-.beta.-D-arabinofuranosyl-5-fluorocytosine | Chemistry; Metallurgy | 3 | Expired |
| US4074042A | Pseudo-isocytidine | Human Necessities | 1 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.